From prototype to clinically deployable device — the science behind quantum-enhanced diagnostics.
Medical imaging has always been a race against noise. Whether it's an MRI scanner or a diagnostic biosensor, the fundamental challenge is the same: extract a clear, meaningful signal from a body that's constantly generating interference. Quantum sensing attacks this problem at its physical root, using quantum-mechanical effects to detect signals with a sensitivity that classical sensors simply cannot reach.
Classical sensors measure physical quantities — magnetic fields, light, temperature — using classical properties of matter. Quantum sensors instead exploit quantum phenomena like superposition and entanglement to measure these same quantities with dramatically higher precision, because quantum states are exquisitely sensitive to their environment. That sensitivity, which is a liability for a quantum computer trying to preserve a stable qubit, becomes an asset for a sensor trying to detect the faintest possible signal.
Conventional MRI relies on the magnetic properties of hydrogen nuclei and classical signal processing to build an image. Quantum-enhanced imaging techniques — including quantum-assisted magnetometry and nitrogen-vacancy (NV) diamond sensing — can detect magnetic fields orders of magnitude weaker than what standard MRI hardware resolves. In practice, that means the theoretical ability to catch structural or metabolic changes earlier, before a condition is visible on a standard scan — precisely the "earlier, more precise diagnosis" objective driving research at our Quantum MedTech Lab.
Beyond imaging, quantum sensing enables biosensors capable of detecting biomarkers at extremely low concentrations — relevant for early cancer detection, infectious disease screening, and monitoring biomarkers that classical assays struggle to pick up until a condition has already progressed. The same underlying quantum sensitivity that improves imaging resolution also improves the detection threshold of these sensors.
A quantum sensing breakthrough in a physics lab is a long way from a device a hospital can actually use. The path runs through validation, calibration against clinical gold standards, regulatory approval, and manufacturing at a cost and reliability level that healthcare systems can adopt. This is measured using Technology Readiness Levels (TRL) — a framework for tracking exactly how far a technology has moved from theoretical demonstration toward deployable product. It's a deliberately unglamorous, rigorous process, and it's where most of the real engineering work in quantum MedTech actually happens.
Precision alone isn't the whole story. Quantum sensors, once productised, can often be built smaller and more ruggedly than the large superconducting magnets required for classical MRI — opening a path toward edge-deployable diagnostic devices for primary health centres and locations that could never host a conventional imaging suite. That's a meaningful equity dimension to this research, not just a technical one.
Quantum sensing doesn't replace medical imaging as we know it — it extends what's physically detectable, pushing the floor of diagnostic sensitivity lower than classical physics allows. Turning that extension into a device a clinician can actually rely on is exactly the translational research problem Quantum MedTech Lab exists to solve.